NIAID Banner Logo Image

Mycobacterium Citations List: November, 2018

Literature Citations

1. Clickable Conjugates of Bile acids and Nucleosides: Synthesis, Characterization, in Vitro Anticancer and Antituberculosis Studies. Agarwal, D.S., V. Siva Krishna, D. Sriram, P. Yogeeswari, and R. Sakhuja. Steroids, 2018. 139: p. 35-44. PMID[30236620].
[PubMed]. TB_11_2018.

2. A Series of Lanthanide Complexes with 2-Fluoro-N'-(furan-2-ylmethylene) benzohydrazide Ligand: Synthesis, Characterization, Luminescent Properties and Biological Evaluation. Ajlouni, A.M, Z.A. Taha, A.K. Hijazi, and W.M. Al-Momani. Applied Organometallic Chemistry, 2018. 32(11). e4536. ISI[000448052500019].
[WOS]. TB_11_2018.

3. 1-(2-Hydroxybenzoy1)-thiosemicarbazides are Promising Antimicrobial Agents Targeting D-Alanine-D-Alanine Ligase in Bacterio. Ameryckx, A., L. Thabault, L. Pochet, S. Leimanis, J.H. Poupaert, J. Wouters, B. Joris, F.V. Bambeke, and R. Frederick. European Journal of Medicinal Chemistry, 2018. 159: p. 324-338. PMID[30300845].
[PubMed]. TB_11_2018.

4. Conventional and Microwave-assisted Synthesis of New Indole-tethered Benzimidazole-based 1,2,3-Triazoles and Evaluation of Their Antimycobacterial, Antioxidant and Antimicrobial Activities. Ashok, D., S. Gundu, V.K. Aamate, and M.G. Devulapally. Molecular Diversity, 2018. 22(4): p. 769-778. PMID[29671194].
[PubMed]. TB_11_2018.

5. Protective Effects of a Traditional Herbal Extract from Stellaria dichotoma var. lanceolata against Mycobacterium abscessus Infections. Bae, S.J., J.W. Choi, B.J. Park, J. Lee, E.K. Jo, Y.H. Lee, S.B. Kim, and J.M. Yuk. Plos One, 2018. 13(11). e0207696. PMID[30452471].
[PubMed]. TB_11_2018.

6. A Class of Hydrazones are Active against Non-replicating Mycobacterium tuberculosis. Bonnett, S.A., D. Dennison, M. Files, A. Bajpai, and T. Parish. Plos One, 2018. 13(10). e0198059. PMID[30332412]. PMCID[PMC6192558].
[PubMed]. TB_11_2018.

7. In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria. Brown-Elliott, B.A., A. Rubio, and R.J. Wallace, Jr. Antimicrobial Agents and Chemotherapy, 2018. 62(11): e01503-01518. PMID[30126964]. PMCID[PMC6201134].
[PubMed]. TB_11_2018.

8. Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis. Cao, R., G. Teskey, H. Islamoglu, R. Abrahem, S. Munjal, K. Gyurjian, L. Zhong, and V. Venketaraman. Antimicrobial Agents and Chemotherapy, 2018. 62(11): e01132-01118. PMID[30126957]. PMCID[PMC6201097].
[PubMed]. TB_11_2018.

9. Effect of the BTK Inhibitor Ibrutinib on Macrophage- and Gammadelta T Cell-mediated Response against Mycobacterium tuberculosis. Colado, A., M. Genoula, C. Cougoule, J.L. Marin Franco, M.B. Almejun, D. Risnik, D. Kviatcovsky, E. Podaza, E.E. Elias, F. Fuentes, I. Maridonneau-Parini, F.R. Bezares, H. Fernandez Grecco, M. Cabrejo, C. Jancic, M.D.C. Sasiain, M. Giordano, R. Gamberale, L. Balboa, and M. Borge. Blood Cancer Journal, 2018. 8(11): p. 100. PMID[30397191]. PMCID[PMC6218455].
[PubMed]. TB_11_2018.

10. Pyrrolidine Nucleoside Bisphosphonates as Antituberculosis Agents Targeting Hypoxanthine-Guanine Phosphoribosyltransferase. Eng, W.S., D. Rejman, R. Pohl, N.P. West, K. Woods, L.M.J. Naesens, D.T. Keough, and L.W. Guddat. European Journal of Medicinal Chemistry, 2018. 159: p. 10-22. PMID[30265958].
[PubMed]. TB_11_2018.

11. Design, Synthesis and Anti-mycobacterial Activity Evaluation of Benzofuran-Isatin Hybrids. Gao, F., H. Yang, T. Lu, Z. Chen, L. Ma, Z. Xu, P. Schaffer, and G. Lu. European Journal of Medicinal Chemistry, 2018. 159: p. 277-281. PMID[30296686].
[PubMed]. TB_11_2018.

12. Novel 5'-Norcarbocyclic pyrimidine Derivatives as Antibacterial Agents. Khandazhinskaya, A.L., L.A. Alexandrova, E.S. Matyugina, P.N. Solyev, O.V. Efremenkova, K.W. Buckheit, M. Wilkinson, R.W. Buckheit, Jr., L.N. Chernousova, T.G. Smirnova, S.N. Andreevskaya, O.G. Leonova, V.I. Popenko, S.N. Kochetkov, and K.L. Seley-Radtke. Molecules, 2018. 23(12). E3069. PMID[30477147].
[PubMed]. TB_11_2018.

13. Synthesis, Antimicrobial Activity and Molecular Modeling Study of 3-(5-Amino-(2H)-1,2,4-triazol-3-yl)-naphthyridinones as Potential DNA-gyrase Inhibitors. Mohamed, N.G., M.M. Sheha, H.Y. Hassan, L.J.M. Abdel-Hafez, and F.A. Omar. Bioorganic Chemistry, 2018. 81: p. 599-611. PMID[30248511].
[PubMed]. TB_11_2018.

14. Oxadiazolone Derivatives, New Promising Multi-target Inhibitors against M. tuberculosis. Nguyen, P.C., V. Delorme, A. Benarouche, A. Guy, V. Landry, S. Audebert, M. Pophillat, L. Camoin, C. Crauste, J.M. Galano, T. Durand, P. Brodin, S. Canaan, and J.F. Cavalier. Bioorganic Chemistry, 2018. 81: p. 414-424. PMID[30212765].
[PubMed]. TB_11_2018.

15. Synthesis, Antimycobacterial Activity, and Acid Dissociation Constants of Polyfunctionalized 3- 2-(Pyrrolidin-1-yl)thiazole-5-carbonyl -2h-chromen-2-one Derivatives. Nural, Y. Monatshefte fur Chemie, 2018. 149(10): p. 1905-1918. ISI[000448664600020].
[WOS]. TB_11_2018.

16. Discovery and Structure-Activity-relationship Study of N-Alkyl-5-hydroxypyrimidinone carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-beta-D-ribose 2'-oxidase. Oh, S., Y. Park, C.A. Engelhart, J.B. Wallach, D. Schnappinger, K. Arora, M. Manikkam, B. Gac, H. Wang, N. Murgolo, D.B. Olsen, M. Goodwin, M. Sutphin, D.M. Weiner, L.E. Via, H.I.M. Boshoff, and C.E. Barry, 3rd. Journal of Medicinal Chemistry, 2018. 61(22): p. 9952-9965. PMID[30350998]. PMCID[PMC6257622].
[PubMed]. TB_11_2018.

17. Study of the Anti(myco)bacterial and Antitumor Activities of Prolinate and N-Amidocarbothiolprolinate Derivatives Based on Fused Tetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione, Bearing an Indole Ring. Poyraz, S., N. Canacankatan, S. Belveren, D. Yetkin, K. Kibar, M. Ulger, J.M. Sansano, N.D. Ozcelik, S.N. Yilmaz, and H.A. Dondas. Monatshefte fur Chemie, 2018. 149(12): p. 2253-2263. ISI[000449934300013].
[WOS]. TB_11_2018.

18. Evaluation of Antimycobacterial and Synergistic Activity of Plants Selected Based on Cheminformatic Parameters. Rahgozar, N., G. Bakhshi Khaniki, and S. Sardari. Iranian Biomedical Journal, 2018. 22(6): p. 401-407. PMID[29510602].
[PubMed]. TB_11_2018.

19. Decavanadate Inhibits Mycobacterial Growth More Potently Than Other Oxovanadates. Samart, N., Z. Arhouma, S. Kumar, H.A. Murakami, D.C. Crick, and D.C. Crans. Frontiers in Chemistry, 2018. 6: p. 519. PMID[30515375]. PMCID[PMC6255961].
[PubMed]. TB_11_2018.

20. Synthetic Thiosemicarbazones as a New Class of Mycobacterium tuberculosis Protein Tyrosine phosphatase A Inhibitors. Sens, L., A.C.A. de Souza, L.A. Pacheco, A.C.O. Menegatti, M. Mori, A. Mascarello, R.J. Nunes, and H. Terenzi. Bioorganic & Medicinal Chemistry, 2018. 26(21): p. 5742-5750. PMID[30389409].
[PubMed]. TB_11_2018.

21. Synthesis and Antimycobacterial Activity of Pyridinium Compounds with Sulfonylacetamide Substituent in N-alkyl Chain. Shulaeva, M.M., M.A. Kravchenko, and V.E. Semenov. Chemistry of Heterocyclic Compounds, 2018. 54(9): p. 868-874. ISI[000449947000007].
[WOS]. TB_11_2018.

22. Synthesis and Antimycobacterial Activity of New N-oxide Compounds Active against Multi-resistant Tuberculosis. Souza, P., G. Fernandes, L. Marino, C. Ribeiro, P. da Silva, M. Chorilli, C. Siva, D. Hunt, L.P. de Carvalho, C.A. Costa, S. Cho, Y.H. Wang, S. Franzblau, C. ManChin, F. Pavan, and J. Dos Santos. Abstracts of Papers of the American Chemical Society, 2018. 256. ISI[000447609102101].
[WOS]. TB_11_2018.

23. In Vitro Inactivation of Mycobacterium avium subsp. paratuberculosis (MAP) by Use of Copper Ions. Steuer, P., C. Avilez, C. Tejeda, N. Gonzalez, A. Ramirez-Reveco, F. Ulloa, A. Mella, I.R. Grant, M.T. Collins, and M. Salgado. BMC Microbiology, 2018. 18(1): p. 172. PMID[30382823]. PMCID[PMC6211491].
[PubMed]. TB_11_2018.

24. Novel N-Thioamide Analogues of Pyrazolylpyrimidine Based Piperazine: Design, Synthesis, Characterization, in-Silico Molecular Docking Study and Biological Evaluation. Vekariya, M.K., D.B. Patel, P.A. Pandya, R.H. Vekariya, P.U. Shah, D.P. Rajani, and N.K. Shah. Journal of Molecular Structure, 2019. 1175: p. 551-565. ISI[000449141100057].
[WOS]. TB_11_2018.

25. The Tyrosine Kinase Inhibitor Dasatinib Reduces the Growth of Intracellular Mycobacterium tuberculosis Despite Impairing T-cell Function. Wehrstedt, S., J. Kubis, A. Zimmermann, H. Bruns, D. Mayer, M. Grieshober, and S. Stenger. European Journal of Immunology, 2018. 48(11): p. 1892-1903. PMID[30242834].
[PubMed]. TB_11_2018.

Patent Citations

26. Sanfetrinem or a Salt or Ester Thereof for Use in Treating Mycobacterial Infection. Barros Aguirre, D., R.H. Bates, R. Gonzalez del Rio, A. Mendoza Losana, and S. Ramon Garcia. Patent. 2018. 2018-EP61615 2018206466: 49pp.
[Patent]. TB_11_2018.

27. Apramycin Derivatives as Antibacterial Agents. Bottger, E.C., S.N. Hobbie, A. Vasella, D. Crich, A. Sonousi, T. Kato, J. Quirke, P. Rajasekaran, and V.A. Sarpe. Patent. 2018. 2018-US30447 2018204358: 91pp.
[Patent]. TB_11_2018.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021